Cargando…

Retraction: Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647891/ https://www.ncbi.nlm.nih.gov/pubmed/31379887 http://dx.doi.org/10.3389/fimmu.2019.01770

Ejemplares similares

Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells
por: Zhu, Liya, et al.
Publicado: (2018)

Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model
por: Tran, Thi-Anh-Thuy, et al.
Publicado: (2023)

iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting
por: Goldenson, Benjamin H., et al.
Publicado: (2022)

Patient’s Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers
por: Messaoudene, Meriem, et al.
Publicado: (2017)

Uterine Natural Killer Cell Heterogeneity: Lessons From Mouse Models
por: Sojka, Dorothy K.
Publicado: (2020)

Modeling Natural Killer Cell Targeted Immunotherapies
por: Lopez-Lastra, Silvia, et al.
Publicado: (2017)

Natural Killer Cell-Derived Exosomal miR-3607-3p Inhibits Pancreatic Cancer Progression by Targeting IL-26
por: Sun, Hongwei, et al.
Publicado: (2019)

Corrigendum: Natural Killer Cell-Derived Exosomal miR-3607-3p Inhibits Pancreatic Cancer Progression by Targeting IL-26
por: Sun, Hongwei, et al.
Publicado: (2020)

Cytokines impact natural killer cell phenotype and functionality against glioblastoma in vitro
por: Sivonen, Minna, et al.
Publicado: (2023)

Targeting Natural Killer Cells for Tumor Immunotherapy
por: Zhang, Cai, et al.
Publicado: (2020)

A humanized mouse model for in vivo evaluation of invariant Natural Killer T cell responses
por: Saavedra-Avila, Noemi Alejandra, et al.
Publicado: (2022)

Natural Killer Cell-Based Cancer Immunotherapies: From Immune Evasion to Promising Targeted Cellular Therapies
por: Hofer, Erhard, et al.
Publicado: (2017)

Enhancing Natural Killer Cell Targeting of Pediatric Sarcoma
por: Omer, Natacha, et al.
Publicado: (2021)

Impact of Aging on the Phenotype of Invariant Natural Killer T Cells in Mouse Thymus
por: Papadogianni, Georgia, et al.
Publicado: (2020)

Transcriptional Regulation of Mouse Tissue-Resident Natural Killer Cell Development
por: Valero-Pacheco, Nuriban, et al.
Publicado: (2020)

Natural-Killer-Derived Extracellular Vesicles: Immune Sensors and Interactors
por: Federici, Cristina, et al.
Publicado: (2020)

Present and Future of Allogeneic Natural Killer Cell Therapy
por: Lim, Okjae, et al.
Publicado: (2015)

Advanced T and Natural Killer Cell Therapy for Glioblastoma
por: Yoon, Wan-Soo, et al.
Publicado: (2023)

From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies
por: Tabellini, Giovanna, et al.
Publicado: (2019)

Natural Killer Cell (NK-92MI)-Based Therapy for Pulmonary Metastasis of Anaplastic Thyroid Cancer in a Nude Mouse Model
por: Zhu, Liya, et al.
Publicado: (2017)

Exosomes Derived From Septic Mouse Serum Modulate Immune Responses via Exosome-Associated Cytokines
por: Gao, Kun, et al.
Publicado: (2019)

Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target
por: Gingrich, Alicia A., et al.
Publicado: (2021)

Corrigendum: Transcriptional Regulation of Mouse Tissue-Resident Natural Killer Cell Development
por: Valero-Pacheco, Nuriban, et al.
Publicado: (2020)

Natural Killer Cells in Asthma
por: Karimi, Khalil, et al.
Publicado: (2013)

Uterine Natural Killer Cells
por: Sojka, Dorothy K., et al.
Publicado: (2019)

Natural Killer Cells in the Lungs
por: Cong, Jingjing, et al.
Publicado: (2019)

Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
por: Kim, Nayoung, et al.
Publicado: (2018)

Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases?
por: Gianchecchi, Elena, et al.
Publicado: (2021)

Multiple Levels of Chemokine Receptor Regulation in the Control of Mouse Natural Killer Cell Development
por: Bernardini, Giovanni, et al.
Publicado: (2014)

Dendritic Cell Derived Cytokines in Human Natural Killer Cell Differentiation and Activation
por: Chijioke, Obinna, et al.
Publicado: (2013)

Natural Killer Cell-Derived Extracellular Vesicles: Novel Players in Cancer Immunotherapy
por: Wu, Feifeng, et al.
Publicado: (2021)

Canine Natural Killer Cell-Derived Exosomes Exhibit Antitumor Activity in a Mouse Model of Canine Mammary Tumor
por: Lee, Jienny, et al.
Publicado: (2021)

Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma
por: Zhu, Liya, et al.
Publicado: (2017)

Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity
por: Dahlberg, Carin I. M., et al.
Publicado: (2015)

Natural Killer Cells: From Basic Research to Treatments
por: Vivier, Eric, et al.
Publicado: (2011)

Natural Killer Cell Immunotherapy: From Bench to Bedside
por: Domogala, Anna, et al.
Publicado: (2015)

Relative expression of receptors in uterine natural killer cells compared to peripheral blood natural killer cells
por: Ismail, Nurul Izza
Publicado: (2023)

Natural Killer Cells Prevent the Formation of Teratomas Derived From Human Induced Pluripotent Stem Cells
por: Benabdallah, Basma, et al.
Publicado: (2019)

Therapeutic Approaches Targeting the Natural Killer-Myeloid Cell Axis in the Tumor Microenvironment
por: Carnevalli, Larissa S., et al.
Publicado: (2021)

Immunoregulatory Effects of Myeloid-Derived Suppressor Cell Exosomes in Mouse Model of Autoimmune Alopecia Areata
por: Zöller, Margot, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9s73gb6rato469v65u1f1pd3nl